Chicago-based Lincoln Park Capital Fund LLC is investing $25 million in TransEnterix Inc. over a 36-month period.
The institutional investor will purchase company stocks at market price during the period to help the company raise funds for general corporate purposes.
TransEnterix is focused on the commercializing of the Senhance surgical robotic system.